Document:

EXHIBIT 10.3

 

THIS WARRANT AND THE COMMON STOCK ISSUABLE
UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON
STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO SEANIEMAC INTERNATIONAL, LTD. THAT SUCH REGISTRATION IS NOT REQUIRED.

 

SEANIEMAC INTERNATIONAL, LTD.

 

WARRANT #1 TO PURCHASE SHARES OF COMMON STOCK

 

1. Issuance.
In consideration of good and valuable consideration as set forth in the Purchase Agreement (defined below), including without limitation
the Purchase Price (as defined in the Purchase Agreement), the receipt and sufficiency of which are hereby acknowledged by Seaniemac
International, Ltd., a Nevada corporation (the “Company”); Iliad
Research and Trading, L.P., a Delaware limited partnership, its successors and/or registered assigns (the “Holder”),
is hereby granted the right to purchase at any time on or after the Issue Date (as defined below) until the date which is the last
calendar day of the month in which the fifth anniversary of the Issue Date occurs (the “Expiration Date”), a
number of fully paid and nonassessable shares (the “Warrant Shares”) of the Company’s common stock, par
value $0.001 per share (the “Common Stock”), equal to $113,750.00 divided by the Market Price (as defined in
the Note, as of the Issue Date), as such number may be adjusted from time to time pursuant to the terms and conditions of this
Warrant #1 to Purchase Shares of Common Stock (this “Warrant”). This Warrant is being issued pursuant to the
terms of that certain Securities Purchase Agreement dated December 2, 2013, to which the Company and the Holder are parties (as
the same may be amended from time to time, the “Purchase Agreement”).

 

Unless otherwise indicated
herein, capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Purchase Agreement.

 

This Warrant was originally
issued to the Holder on December 2, 2013 (the “Issue Date”).

 

2. Exercise of Warrant.

 

2.1. General.

 

(a) This Warrant is
exercisable in whole or in part at any time and from time to time commencing on the Issue Date and ending on the Expiration Date.
Such exercise shall be effectuated by submitting to the Company (either by delivery to the Company or by email or facsimile transmission)
a completed and duly executed Notice of Exercise substantially in the form attached to this Warrant as Exhibit A (the “Notice
of Exercise”). The date such Notice of Exercise is either faxed, emailed or delivered to the Company shall be the “Exercise
Date,” provided that, if such exercise represents the full exercise of the outstanding balance of the Warrant, the Holder
shall tender this Warrant to the Company within five (5) Trading Days thereafter, but only if the Warrant Shares to be delivered
pursuant to the Notice of Exercise have been delivered to the Holder as of such date. The Notice of Exercise shall be executed
by the Holder and shall indicate (i) the number of Delivery Shares (as defined below) to be issued pursuant to such exercise, and
(ii) if applicable (as provided below), whether the exercise is a cashless exercise.

 

    	1

    	 

    

 

For purposes of this Warrant,
the term “Trading Day” means any day during which the principal market on which the Common Stock is traded (the
“Principal Market”) shall be open for business.

 

(b) Notwithstanding
any other provision contained herein or in any other Transaction Document to the contrary, if the Company has not registered the
Warrant Shares and the Conversion Shares (as defined in the Note) under the 1933 Act pursuant to an effective registration statement
within nine (9) months of the Issue Date, then at any time following the date that is nine (9) months from the Issue Date but prior
to the Expiration Date, the Holder may elect a “cashless” exercise of this Warrant for any Warrant Shares whereby the
Holder shall be entitled to receive a number of shares of Common Stock equal to (i) the excess of the Current Market Value (as
defined below) over the aggregate Exercise Price of the Exercise Shares (as defined below), divided by (ii) the Adjusted Price
of the Common Stock (as defined below).

 

For the purposes of this
Warrant, the following terms shall have the following meanings:

 

“Adjusted Price
of the Common Stock” shall mean the lower of (i) the Conversion Price (as defined in the Note, as such Conversion Price
may be adjusted from time to time pursuant to the terms of the Note (solely for the purpose of determining the then-current Conversion
Price under this definition of “Adjusted Price of the Common Stock,” each cashless exercise of this Warrant shall be
deemed a conversion under the Note) , and (ii) the Market Price (as defined in the Note), without regard to whether the Note remains
outstanding or has been fully repaid, cancelled or otherwise retired, on any relevant Exercise Date.

 

“Current Market
Value” shall mean an amount equal to the Market Price of the Common Stock (as defined below), multiplied by the number
of Exercise Shares specified in the applicable Notice of Exercise.

 

“Closing Price”
shall mean the 4:00 P.M. last sale price of the Common Stock on the Principal Market on the relevant Trading Day(s), as reported
by Bloomberg LP (or if that service is not then reporting the relevant information regarding the Common Stock, a comparable reporting
service of national reputation selected by the Holder and reasonably acceptable to the Company) (“Bloomberg”)
for the relevant date.

 

“Delivery Shares”
means those shares of Common Stock issuable and deliverable upon the exercise of this Warrant.

 

“Exercise Price”
shall mean $0.12 per share of Common Stock, as the same may be adjusted from time to time pursuant to the terms and conditions
of this Warrant.

 

“Exercise Shares”
shall mean those Warrant Shares subject to an exercise of the Warrant by the Holder. By way of illustration only and without limiting
the foregoing, if (i) the Warrant is initially exercisable for 4,180,000 Warrant Shares and the Holder has not previously exercised
the Warrant, and (ii) the Holder were to make a cashless exercise with respect to 5,000 Warrant Shares pursuant to which 6,000
Delivery Shares would be issuable to the Holder, then (1) the Warrant shall be deemed to have been exercised with respect to 5,000
Exercise Shares, (2) the Warrant would remain exercisable for 4,175,000 Warrant Shares, and (3) the Warrant shall be deemed to
have been exercised with respect to 6,000 Delivery Shares.

 

    	2

    	 

    

 

“Market Price
of the Common Stock” shall mean the higher of: (i) the Closing Price of the Common Stock on the Issue Date; and (ii)
the VWAP (as defined below) of the Common Stock for the Trading Day that is two (2) Trading Days prior to the Exercise Date.

 

“Note”
shall mean that certain Convertible Promissory Note issued by the Company to the Holder pursuant to the Purchase Agreement, as
the same may be amended from time to time, and including any promissory note(s) that replace or are exchanged for such referenced
promissory note.

 

“Transaction Documents”
or “Transaction Document” shall have the meaning set forth in the Purchase Agreement.

 

“VWAP”
shall mean the volume-weighted average price of the Common Stock on the Principal Market for a particular Trading Day or set of
Trading Days, as the case may be, as reported by Bloomberg.

 

(c) If the Notice of
Exercise form elects a “cash” exercise (or if the cashless exercise referred to in the immediately preceding subsection
(b) is not available in accordance with the terms hereof), the Exercise Price per share of Common Stock for the Delivery Shares
shall be payable, at the election of the Holder, in cash or by certified or official bank check or by wire transfer in accordance
with instructions provided by the Company at the request of the Holder.

 

(d) Upon the appropriate
payment to the Company, if any, of the Exercise Price for the Delivery Shares, together with the surrender of this Warrant (if
required), the Company shall promptly, but in no case later than the date that is three (3) Trading Days following the date the
Exercise Price is paid to the Company (or with respect to a “cashless exercise,” the date that is three (3) Trading
Days following the Exercise Date), deliver or cause the Company’s Transfer Agent to deliver the applicable Delivery Shares
electronically via the Deposit/Withdrawal at Custodian (“DWAC”) system to the account designated by the Holder
on the Notice of Exercise. If for any reason the Company is not able to so deliver the Delivery Shares via the DWAC system, notwithstanding
its best efforts to do so, such shall constitute a breach of this Warrant (and thus an Event of Default under the Note), and the
Company shall instead, on or before the applicable date set forth above in this subsection, issue and deliver to the Holder or
its broker (as designated in the Notice of Exercise), via reputable overnight courier, a certificate, registered in the name of
the Holder or its designee, representing the applicable number of Delivery Shares. For the avoidance of doubt, the Company has
not met its obligation to deliver Delivery Shares within the required timeframe set forth above unless Holder or its broker, as
applicable, has actually received the Delivery Shares (whether electronically or in certificated form) no later than the close
of business on the latest possible delivery date pursuant to the terms set forth above.

 

(e) If Delivery Shares
are delivered later than as required under subsection (d) immediately above, the Company agrees to pay, in addition to all other
remedies available to the Holder in the Transaction Documents, a late charge equal to the greater of (i) $2,000.00 and (ii) 2%
of the product of (1) the sum of the number of shares of Common Stock not issued to the Holder on a timely basis and to which
the Holder is entitled multiplied by (2) the Closing Sale Price (as defined in the Note) of the Common Stock on the Trading
Day immediately preceding the last possible date which the Company could have issued such shares of Common Stock to the Holder
without violating this Warrant, per Trading Day until such Delivery Shares are delivered. The Company shall pay any late charges
incurred under this subsection in immediately available funds upon demand; provided, however, that, at the option of the
Holder (without notice to the Company), such amount owed may be added to the principal amount of the Note. Furthermore, in addition
to any other remedies which may be available to the Holder, in the event that the Company fails for any reason to effect delivery
of the Delivery Shares as required under subsection (d) immediately above, the Holder may revoke all or part of the relevant Warrant
exercise by delivery of a notice to such effect to the Company, whereupon the Company and the Holder shall each be restored to
their respective positions immediately prior to the exercise of the relevant portion of this Warrant, except that the late charge
described above shall be payable through the date notice of revocation or rescission is given to the Company.

 

    	3

    	 

    

 

(f) The Holder shall
be deemed to be the holder of the Delivery Shares issuable to it in accordance with the provisions of this Section 2.1 on the Exercise
Date.

 

2.2. Ownership Limitation.
Notwithstanding anything to the contrary contained in this Warrant or the other Transaction Documents, if at any time the Holder
shall or would be issued shares of Common Stock under any of the Transaction Documents, but such issuance would cause the Holder
(together with its Affiliates) to own a number of shares exceeding 4.99% of the number of shares of Common Stock outstanding on
such date (the “Maximum Percentage”), the Company must not issue to the Holder shares of the Common Stock which
would exceed the Maximum Percentage. The shares of Common Stock issuable to the Holder that would cause the Maximum Percentage
to be exceeded are referred to herein as the “Ownership Limitation Shares”. The Company will reserve
the Ownership Limitation Shares for the exclusive benefit of the Holder. From time to time, the Holder may notify the Company in
writing of the number of the Ownership Limitation Shares that may be issued to the Holder without causing the Holder to exceed
the Maximum Percentage. Upon receipt of such notice, the Company shall be unconditionally obligated to immediately issue such designated
shares to the Holder, with a corresponding reduction in the number of the Ownership Limitation Shares. Notwithstanding the forgoing,
the term “4.99%” above shall be replaced with “9.99%” at such time as the Market Capitalization of the
Common Stock is less than $10,000,000.00. Notwithstanding any other provision contained herein, if the term “4.99%”
is replaced with “9.99%” pursuant to the preceding sentence, such change to “9.99%” shall be permanent.
For purposes of this Agreement, the term “Market Capitalization of the Common Stock” shall mean the product
equal to (A) the average VWAP (as defined in the Note) of the Common Stock for the immediately preceding fifteen (15) Trading Days,
multiplied by (B) the aggregate number of outstanding shares of Common Stock as reported on the Company’s most recently filed
Form 10-Q or Form 10-K. By written notice to the Company, the Holder may increase, decrease or waive the Maximum Percentage as
to itself but any such waiver will not be effective until the 61st day after delivery thereof. The foregoing 61-day notice requirement
is enforceable, unconditional and non-waivable and shall apply to all Affiliates and assigns of the Holder.

 

3. Mutilation or
Loss of Warrant. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of
this Warrant, and (in the case of loss, theft or destruction) receipt of reasonably satisfactory indemnification, and (in the case
of mutilation) upon surrender and cancellation of this Warrant, the Company will execute and deliver to the Holder a new Warrant
of like tenor and date and any such lost, stolen, destroyed or mutilated Warrant shall thereupon become void.

 

4. Rights of the
Holder. The Holder shall not, by virtue of this Warrant alone, be entitled to any rights of a stockholder in the Company, either
at law or in equity, and the rights of the Holder with respect to or arising under this Warrant are limited to those expressed
in this Warrant and are not enforceable against the Company except to the extent set forth herein.

 

    	4

    	 

    

 

5. Protection Against
Dilution and Other Adjustments.

 

5.1. Capital Adjustments.
If the Company shall at any time prior to the expiration of this Warrant subdivide the Common Stock, by split-up or stock split,
or otherwise, or combine its Common Stock, or issue additional shares of its Common Stock as a dividend, the number of Warrant
Shares issuable upon the exercise of this Warrant shall forthwith be automatically increased proportionately in the case of a subdivision,
split or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made
to the Exercise Price, Conversion Price (in the event of a cashless exercise), and other applicable amounts, but the aggregate
purchase price payable for the total number of Warrant Shares purchasable under this Warrant (as adjusted) shall remain the same.
Any adjustment under this Section 5.1 shall become effective automatically at the close of business on the date the subdivision
or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon
the making of such dividend.

 

5.2. Reclassification,
Reorganization and Consolidation. In case of any reclassification, capital reorganization, or change in the capital stock of
the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 5.1 above), then
the Company shall make appropriate provision so that the Holder shall have the right at any time prior to the expiration of this
Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of
stock and other securities and property receivable in connection with such reclassification, reorganization, or change by a holder
of the same number of shares of Common Stock as were purchasable by the Holder immediately prior to such reclassification, reorganization,
or change. In any such case appropriate provisions shall be made with respect to the rights and interest of the Holder so that
the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable
upon exercise hereof, and appropriate adjustments shall be made to the purchase price per Warrant Share payable hereunder, provided
the aggregate purchase price shall remain the same.

 

5.3. Subsequent Equity
Sales. If the Company or any subsidiary thereof, as applicable, at any time and from time to time while this Warrant is outstanding,
shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition of) any Common Stock (including any Common Stock issued under
the Note, whether upon any type of conversion or any Deemed Issuance (as defined in the Note)), preferred shares convertible into
Common Stock, or debt, warrants, options or other instruments or securities which are convertible into or exercisable for shares
of Common Stock (together herein referred to as “Equity Securities”), at an effective price per share less than
the Exercise Price (such lower price, the “Base Share Price” and such issuance collectively, a “Dilutive
Issuance”) (if the holder of the Common Stock or Equity Securities so issued shall at any time, whether by operation
of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants,
options, or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at
an effective price per share that is less than the Exercise Price, such issuance shall be deemed to have occurred for less than
the Exercise Price on such date of the Dilutive Issuance), then (a) the Exercise Price shall be reduced and only reduced to equal
the Base Share Price, and (b) the number of Warrant Shares issuable upon the exercise of this Warrant shall be increased to an
amount equal to the number of Warrant Shares the Holder could purchase hereunder for an aggregate Exercise Price, as reduced pursuant
to subsection (a) above, equal to the aggregate Exercise Price payable immediately prior to such reduction in Exercise Price. Such
adjustments shall be made whenever such Common Stock or Equity Securities are issued. The Company shall notify the Holder, in writing,
no later than the Trading Day following the issuance of any Common Stock or Equity Securities subject to this Section 5.3, indicating
therein the applicable issuance price, or applicable reset price, exchange price, conversion price, or other pricing terms (such
notice, the “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides
a Dilutive Issuance Notice pursuant to this Section 5.3, upon the occurrence of any Dilutive Issuance, after the date of such Dilutive
Issuance the Holder is entitled to receive the increased number of Warrant Shares provided for in subsection (b) above at an Exercise
Price equal to the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of
Exercise. Additionally, following the occurrence of a Dilutive Issuance, all references in this Warrant to “Warrant Shares”
shall be a reference to the Warrant Shares as increased pursuant to subsection (b) above, and all references in this Warrant to
“Exercise Price” shall be a reference to the Exercise Price as reduced pursuant to subsection (a) above, as the same
may occur from time to time hereunder.

 

    	5

    	 

    

 

5.4. Notice of Adjustment.
Without limiting any other provision contained herein, when any adjustment is required to be made in the number or kind of shares
purchasable upon exercise of this Warrant, or in the Exercise Price, pursuant to the terms hereof, the Company shall promptly notify
the Holder of such event and of the number of Warrant Shares or other securities or property thereafter purchasable upon exercise
of this Warrant.

 

5.5. Exceptions to
Adjustment. Notwithstanding the provisions of Sections 5.3 and 5.4, no adjustment to the Exercise Price shall be effected as
a result of an Excepted Issuance. “Excepted Issuances” shall mean, collectively, (a) the Company’s issuance
of securities in connection with strategic license agreements and other partnering arrangements so long as any such issuances are
not for the purpose of raising capital and in which holders of such securities or debt are not at any time granted registration
rights, and (b) the Company’s issuance of Common Stock or the issuance or grant of options to purchase Common Stock to employees,
directors, officers and consultants, authorized by the Company’s board of directors pursuant to plans or agreements which
are authorized, constituted or in effect as of the Issue Date.

 

6. Certificate as
to Adjustments. In each case of any adjustment or readjustment in the shares of Common Stock issuable on the exercise of this
Warrant, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee to compute such
adjustment or readjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment
or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a)
the consideration received or receivable by the Company for any additional shares of Common Stock issued or sold or deemed to have
been issued or sold, (b) the number of shares of Common Stock outstanding or deemed to be outstanding, and (c) the Exercise Price
and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately prior to such adjustment
or readjustment and as adjusted or readjusted as provided in this Warrant. The Company will forthwith mail a copy of each such
certificate to the Holder and any Warrant Agent (as defined below) appointed pursuant to Section 8 hereof. Nothing in this Section
6 shall be deemed to limit any other provision contained herein.

 

7. Transfer to Comply
with the Securities Act. This Warrant, and the Warrant Shares, have not been registered under the 1933 Act. None of the Warrant
Shares may be sold, transferred, pledged or hypothecated without (a) an effective registration statement under the 1933 Act relating
to such security or (b) an opinion of counsel reasonably satisfactory to the Company that registration is not required under the
1933 Act; provided, however, that the foregoing restrictions on transfer shall not apply to the transfer of any security
to an affiliate of the Holder. Until such time as registration has occurred under the 1933 Act, each certificate for this Warrant
and any Warrant Shares shall contain a legend, in form and substance satisfactory to counsel for the Company, setting forth the
restrictions on transfer contained in this Section 7. Any such transfer shall be accompanied by a transferor assignment substantially
in the form attached to this Warrant as Exhibit B (the “Transferor Assignment”), executed by the transferor
and the transferee and submitted to the Company. Upon receipt of the duly executed Transferor Assignment, the Company shall register
the transferee thereon as the new Holder on the books and records of the Company and such transferee shall be deemed a “registered
holder” or “registered assign” for all purposes hereunder, and shall have all the rights of the Holder.

 

    	6

    	 

    

 

8. Warrant Agent.
The Company may, by written notice to the Holder, appoint an agent (a “Warrant Agent”) for the purpose of issuing
shares of Common Stock on the exercise of this Warrant pursuant hereto, exchanging this Warrant pursuant hereto, and replacing
this Warrant pursuant hereto, or any of the foregoing, and thereafter any such issuance, exchange or replacement, as the case may
be, shall be made at such office by such Warrant Agent.

 

9. Transfer on the
Company’s Books. Until this Warrant is transferred on the books of the Company, the Company may treat the Holder as the
absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

10. Notices.
Any notice required or permitted hereunder shall be given in the manner provided in the subsection titled “Notices”
in the Purchase Agreement, the terms of which are incorporated herein by reference.

 

11. Supplements and
Amendments; Whole Agreement. This Warrant may be amended or supplemented only by an instrument in writing signed by the
parties hereto. This Warrant, together with the Purchase Agreement and all the other Transaction Documents, taken together, contain
the full understanding of the parties hereto with respect to the subject matter hereof and thereof and there are no representations,
warranties, agreements or understandings with respect to the subject matter hereof and thereof other than as expressly contained
herein and therein.

 

12. Governing Law.
This Warrant shall be governed by and interpreted in accordance with the laws of the State of Illinois, without giving effect to
the principles thereof regarding the conflict of laws. The Company and, by accepting this Warrant, the Holder, each irrevocably
(a) consents to and expressly submits to the exclusive personal jurisdiction of any state or federal court sitting in Cook County,
Illinois in connection with any dispute or proceeding arising out of or relating to this Warrant, (b) agrees that all claims in
respect of any such dispute or proceeding may only be heard and determined in any such court, (c) expressly submits to the venue
of any such court for the purposes hereof, and (d) waives any claim of improper venue and any claim or objection that such courts
are an inconvenient forum or any other claim or objection to the bringing of any such proceeding in such jurisdictions or to any
claim that such venue of the suit, action or proceeding is improper. The Company and, by accepting this Warrant, the Holder, each
hereby irrevocably consents to the service of process of any of the aforementioned courts in any such proceeding by the mailing
of copies thereof by reputable overnight courier (e.g., FedEx) or certified mail, postage prepaid, to such party’s address
as provided for herein, such service to become effective ten (10) calendar days after such mailing. THE COMPANY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

13. Remedies.
The remedies at law of the Holder of this Warrant in the event of any default or threatened default by the Company in the performance
of or compliance with any of the terms of this Warrant are not and will not be adequate and, without limiting any other remedies
available to the Holder in the Transaction Documents, law or equity, to the fullest extent permitted by law, such terms may be
specifically enforced by a decree for the specific performance of any agreement contained herein or by an injunction against a
violation of any of the terms hereof or otherwise.

 

    	7

    	 

    

 

14. Counterparts.
This Warrant may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be
an original, and all such counterparts shall together constitute but one and the same instrument. Signature delivered via facsimile
or email shall be considered original signatures for purposes hereof.

 

15. Attorney’s
Fees. In the event of any litigation or dispute arising from this Warrant, the parties agree that the party who is awarded
the most money shall be deemed the prevailing party for all purposes and shall therefore be entitled to an additional award of
the full amount of the attorneys’ fees and expenses paid by said prevailing party in connection with the litigation
and/or dispute without reduction or apportionment based upon the individual claims or defenses giving rise to the fees and
expenses. Nothing herein shall restrict or impair a court’s power to award fees and expenses for frivolous or bad faith pleading.

 

16. Severability.
Whenever possible, each provision of this Warrant shall be interpreted in such a manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be invalid or unenforceable in any jurisdiction, such provision shall be modified
to achieve the objective of the parties to the fullest extent permitted and such invalidity or unenforceability shall not affect
the validity or enforceability of the remainder of this Warrant or the validity or enforceability of this Warrant in any other
jurisdiction.

 

17. Time of the Essence.
Time is expressly made of the essence of each and every provision of this Warrant.

 

18. Descriptive Headings.
Descriptive headings of the sections of this Warrant are inserted for convenience only and shall not control or affect the meaning
or construction of any of the provisions hereof.

 

[Remainder of page intentionally left blank]

 

    	8

    	 

    

 

IN WITNESS WHEREOF, the
Company has caused this Warrant to be duly executed by an officer thereunto duly authorized as of the Issue Date.

 

	 	COMPANY:
	 	 	 
	 	Seaniemac International, Ltd.
	 	 	 
	 	By:	 

 

	 	Printed Name:	 

 

	 	Title:	 

 

[Signature
page to Warrant #1]

 

    	9

    	 

    

 

EXHIBIT A

 

NOTICE OF EXERCISE OF WARRANT

 

	TO:	SEANIEMAC INTERNATIONAL, LTD.
	 	ATTN: _______________
	 	VIA FAX TO: ( )______________

 

The undersigned hereby
irrevocably elects to exercise the right, represented by the Warrant to Purchase Shares of Common Stock dated as of December 2,
2013 (the “Warrant”), to purchase shares of the common stock, $0.001 par value (“Common Stock”),
of SEANIEMAC INTERNATIONAL, LTD., and tenders herewith payment in accordance with Section 2 of the Warrant, as follows:

 

	_______	 	CASH: $__________________________ = (Exercise Price x Delivery Shares)
	 	 	 
	_______	 	Payment is being made by:
	 	 	_____ 	enclosed check 
	 	 	_____	wire transfer 
	 	 	_____	other

 

	_______	 	CASHLESS EXERCISE:
	 	 	 
	 	 	Net number of Delivery Shares to be issued to Holder: ______*

 

	 	 	* based on:	 	Current Market Value - (Exercise Price x Exercise Shares)
	 	 	 	 	Adjusted Price of the Common Stock

 

	 	 	Where:	 	 	 	 
	 	 	Market Price of the Common Stock [“MP”]	 	=	 	$____________
	 	 	Exercise Shares	 	=	 	_____________
	 	 	Current Market Value [MP x Exercise Shares] 	 	=	 	$____________
	 	 	Exercise Price	 	=	 	$____________
	 	 	Adjusted Price of the Common Stock	 	=	 	$____________

 

Capitalized terms used
but not otherwise defined herein shall have the meanings ascribed to them in the Warrant.

 

It is the intention of
the Holder to comply with the provisions of Section 2.2 of the Warrant regarding certain limits on the Holder’s right to
receive shares thereunder. The Holder believes this exercise complies with the provisions of such Section 2.2. Nonetheless, to
the extent that, pursuant to the exercise effected hereby, the Holder would receive more shares of Common Stock than permitted
under Section 2.2, the Company shall not be obligated and shall not issue to the Holder such excess shares until such time, if
ever, that the Holder could receive such excess shares without violating, and in full compliance with, Section 2.2 of the Warrant.

 

As contemplated by the
Warrant, this Notice of Exercise is being sent by facsimile to the fax number and officer indicated above.

  

    	10

    	 

    

 

If this Notice of Exercise
represents the full exercise of the outstanding balance of the Warrant, the Holder either (1) has previously surrendered the Warrant
to the Company or (2) will surrender (or cause to be surrendered) the Warrant to the Company at the address indicated above by
express courier within five (5) Trading Days after delivery or email or facsimile transmission of this Notice of Exercise; provided
that the Warrant Shares to be delivered pursuant to this Notice of Exercise have been delivered to the Holder as of such date.

 

To the extent the Delivery
Shares are not able to be delivered to the Holder via the DWAC system, please deliver certificates representing the Delivery Shares
to the Holder via reputable overnight courier after receipt of this Notice of Exercise (by facsimile transmission or otherwise)
to:

 

	 
	 
	 

 

	Dated:	 	 
	 	 	 
	 	 
	[Name of Holder]	 
	 	 	 
	By:	 	 

 

    	11

    	 

    

 

EXHIBIT B

 

FORM OF TRANSFEROR ENDORSEMENT

(To be signed only on transfer of the Warrant)

 

For value received, the undersigned
hereby sells, assigns, and transfers unto the person(s) named below under the heading “Transferees” the right represented
by the Warrant to Purchase Shares of Common Stock dated as of December 2, 2013 (the “Warrant”) to purchase the
percentage and number of shares of common stock, $0.001 par value (“Common Stock”), of SEANIEMAC INTERNATIONAL,
LTD. specified under the headings “Percentage Transferred” and “Number Transferred,” respectively, opposite
the name(s) of such person(s), and appoints each such person attorney to transfer the undersigned’s respective right on the
books of SEANIEMAC INTERNATIONAL, LTD. with full power of substitution in the premises.

 

	Transferees	 	Percentage Transferred	 	Number Transferred

 

Dated:___________, ______

 

	 	 
	 	[Transferor Name must conform to the name of Holder as specified on the face of the Warrant]
	 	 	 
	 	By:	 
	 	Name:	 

 

	Signed in the presence of:	 
	 	 	 
	 	 
	(Name)	 
	 	 	 
	ACCEPTED AND AGREED:	 
	 	 	 
	 	 
	[TRANSFEREE] 	 
	 	 	 
	By:	 	 
	Name:	 	 

 

    	12EXHIBIT 10.4

 

THIS
NOTE MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE ALIENATED OR ENCUMBERED WITHOUT THE PRIOR WRITTEN
CONSENT OF THE BORROWER.

 

	 

        $100,000.00
	State
                                                                                                                of Illinois

        December
        2, 2013

 

BUYER
NOTE #1

 

FOR
VALUE RECEIVED, Iliad Research and Trading, L.P., a Delaware limited partnership
(the “Borrower”), hereby promises to pay to Seaniemac International,
Ltd., a Nevada corporation (the “Lender,” and together with the Borrower, the “Parties”),
the principal sum of $100,000.00 together with all accrued and unpaid interest thereon, fees incurred or other amounts owing hereunder,
all as set forth below in this Buyer Note #1 (this “Note”). This Note is issued pursuant to that certain Securities
Purchase Agreement of even date herewith, entered into by and between the Borrower and the Lender (as the same may be amended
from time to time, the “Purchase Agreement”), pursuant to which the Lender issued to the Borrower that certain
Secured Convertible Promissory Note in the principal amount of $667,500.00 (as the same may be amended from time to time, the
“Lender Note”) convertible into shares of the Company’s Common Stock. All capitalized terms used but
not otherwise defined herein shall have the meanings ascribed thereto in the Purchase Agreement.

 

1. Principal
and Interest. Interest shall accrue on the unpaid principal
balance and any unpaid late fees or other fees under this Note at a rate of eight percent (8.0%) per annum until the full
amount of the principal and fees has been paid. Interest shall be computed on the
basis of a 365-day year for the actual number of days elapsed. Notwithstanding any provision to the contrary herein, in no
event shall the applicable interest rate at any time exceed the maximum interest rate allowed under applicable law, as
provided in Section 11 below. The entire unpaid principal balance and all accrued and unpaid interest, if any, under this
Note, shall be due and payable on the date (such date is referred to as the “Buyer Note Maturity Date”)
that is twenty-three (23) months after the Closing Date (as defined in the Purchase Agreement).

 

2.
Payment.Unless prepaid, all principal and accrued interest under this Note is payable in one lump sum on the Buyer Note
Maturity Date. All payments of interest and principal shall be (i) in lawful money of the United States of America, and (ii) in
the form of immediately available funds. All payments shall be applied first to costs of collection, if any, then to accrued and
unpaid interest, and thereafter to principal. Payment of principal and interest hereunder shall be delivered to the Lender at
the address furnished to the Borrower for that purpose.

 

3.
Prepayment by the Borrower. The Borrower may, with Lender’s consent, pay, without penalty, all or any portion of
the outstanding balance along with any accrued but unpaid interest on this Note at any time prior to the Buyer Note Maturity Date.

 

4.
Security; Collateral. The Borrower may, in its sole discretion, designate collateral (the “Collateral”)
as it deems fit, as security for the Borrower’s obligations hereunder, which Collateral may be, but is not required to be,
real property, a letter of credit with a financial institution determined by the Borrower in its sole discretion, or pledged membership
interests, provided that the net fair market value of the Collateral (net of any outstanding monetary liens) shall not be less
than the principal balance of this Note as of the date of any such designation. Upon the Borrower’s designation of Collateral,
each of the Borrower and the Lender shall timely execute any and all documents necessary or advisable in order to properly grant
a security interest upon the Collateral in favor of the Lender.

 

    	 

    	 

    

 

5.
Release. The Lender covenants and agrees that in the event that this Note is secured
by Collateral, the Lender shall timely execute any and all documents necessary or advisable in order to release such security
interest and Collateral to Borrower, or Borrower’s designee, upon the earlier of (i) the date this Note is paid in full
and (ii) the date that is six (6) months and three (3) days following the date such Collateral is given as security for this Note,
or such later date as determined in the sole discretion of the Borrower (the “Release Date”). For avoidance
of doubt, as of the date hereof, there is no collateral securing this Note, and after the Release Date, as applicable, there shall
be no collateral securing this Note.

 

6.
Right of Offset. Notwithstanding anything to the contrary herein or in any of the other Transaction Documents, in the event
(i) of the occurrence of any Event of Default (as defined in the Lender Note) under the Lender Note or any other note issued by
the Lender in connection with the Purchase Agreement, (ii) the Borrower exercises any Event of Default Redemption Right or Fundamental
Transaction Redemption Right (as such terms are defined in the Lender Note) under the Lender Note, (iii) the Lender Note is accelerated
for any reason, or (iv) of a breach of any material term, condition, representation, warranty, covenant or obligation of the Lender
under any Transaction Document, the Borrower shall be entitled to deduct and offset any amount owing by the Lender under the Lender
Note from any amount owed by the Borrower under this Note. In the event that the Borrower’s exercise
of its offset rights under this Section 6 results in the full satisfaction of the Borrower’s obligations under this Note,
then the Lender shall return this Note to the Borrower for cancellation or, in the event this Note has been lost, stolen or destroyed,
the Lender shall provide the Borrower with a lost note affidavit in a form reasonably acceptable to the Borrower.

 

7.
Default. If any of the events specified below shall occur (each, an “Event of Default”) the Lender may
declare the unpaid principal balance under this Note, together with all accrued and unpaid interest thereon, fees incurred or
other amounts owing hereunder immediately due and payable, by notice in writing to the Borrower. If
any default, other than a Payment Default (as defined below), is curable, then the default may be cured (and no Event of Default
will have occurred) if the Borrower, after receiving written notice from the Lender demanding cure of such default, either (a)
cures the default within fifteen (15) days of the receipt of such notice, or (b) if the cure requires more than fifteen (15) days,
immediately initiates steps that the Lender deems in the Lender’s reasonable discretion to be sufficient to cure the default
and thereafter diligently continues and completes all reasonable and necessary steps sufficient to produce compliance as soon
as reasonably practical. Each of the following events shall constitute an Event of Default:

 

7.1.
Failure to Pay. The Borrower’s failure to make any payment when due and payable under this Note (a “Payment
Default”);

 

7.2.
Breaches of Covenants. The Borrower’s failure to observe or perform any other covenant, obligation, condition or
agreement contained in this Note;

 

7.3.
Representations and Warranties. If any representation, warranty, certificate, or other statement (financial or otherwise)
made or furnished by or on behalf of the Borrower to the Lender in writing in connection with this Note or any of the other Transaction
Documents, or as an inducement to the Lender to enter into the Purchase Agreement, shall be false, incorrect, incomplete or misleading
in any material respect when made or furnished; and

 

7.4.
Involuntary Bankruptcy. If any involuntary petition is filed under any bankruptcy or similar law or rule against the Borrower,
and such petition is not dismissed within sixty (60) days, or a receiver, trustee, liquidator, assignee, custodian, sequestrate
or other similar official is appointed to take possession of any of the assets or properties of the Borrower or any guarantor.

 

    	2

    	 

    

 

8.
Binding Effect; Assignment. This Note shall be binding on the Parties and their respective heirs, successors, and assigns;
provided, however, that neither party shall assign any of its rights hereunder without the prior written consent
of the other party, except that the Borrower may assign this Note to any of its Affiliates without the prior written consent of
the Lender and, furthermore, the Lender agrees that it shall not unreasonably withhold, condition or delay its consent to any
other assignment of this Note by the Borrower.

 

9.
Governing Law; Venue. The terms of this Note shall be construed in accordance with the laws of the State of Illinois as
applied to contracts entered into by Illinois residents within the State of Illinois which contracts are to be performed entirely
within the State of Illinois. With respect to any disputes arising out of or related to this Note, the Parties consent to the
exclusive personal jurisdiction of, and venue in, the state courts located in Cook County, State of Illinois (or in the event
of federal jurisdiction, the United States District Court for the Northern District of Illinois - Eastern Division), and
hereby waive, to the maximum extent permitted by law, any objection, including any objection based on forum non conveniens,
to the bringing of any such proceeding in such jurisdiction or to any claim that such venue of the suit, action or proceeding
is improper.

 

10.
Customer Identification–USA Patriot Act Notice. The Lender hereby notifies the Borrower that pursuant to the requirements
of the USA Patriot Act (Title III of Pub. L. 107-56, signed into law October 26, 2001) (the “Act”), and the
Lender’s policies and practices, the Lender is required to obtain, verify and record certain information and documentation
that identifies the Borrower, which information includes the name and address of the Borrower and such other information that
will allow the Lender to identify the Borrower in accordance with the Act.

 

11.
Lawful Interest. It being the intention of the Lender and the Borrower to comply with all applicable laws with regard to
the interest charged hereunder, it is agreed that, notwithstanding any provision to the contrary in this Note or any of the other
Transaction Documents, no such provision, including without limitation any provision of this Note providing for the payment of
interest or other charges, shall require the payment or permit the collection of any amount in excess of the maximum amount of
interest permitted by law to be charged for the use or detention, or the forbearance in the collection, of all or any portion
of the indebtedness evidenced by this Note or by any extension or renewal hereof (“Excess Interest”). If any
Excess Interest is provided for, or is adjudicated to be provided for, in this Note or any of the other Transaction Documents,
then in such event:

 

11.1.
the provisions of this Section 11 shall govern and control;

 

11.2.
the Borrower shall not be obligated to pay any Excess Interest;

 

11.3.
any Excess Interest that the Lender may have received hereunder shall, at the option of the Lender, be (i) applied as a credit
against the principal balance due under this Note or the accrued and unpaid interest thereon not to exceed the maximum amount
permitted by law, or both, (ii) refunded to the Borrower, or (iii) any combination of the foregoing;

 

11.4.
the applicable interest rate or rates shall be automatically subject to reduction to the maximum lawful rate allowed to be contracted
for in writing under the applicable governing usury laws, and this Note and the Transaction Documents shall be deemed to have
been, and shall be, reformed and modified to reflect such reduction in such interest rate or rates; and

 

11.5.
the Borrower shall not have any action or remedy against the Lender for any damages whatsoever or any defense to enforcement of
this Note or arising out of the payment or collection of any Excess Interest.

 

    	3

    	 

    

 

12.
Pronouns. Regardless of their form, all words used in this Note shall be deemed singular or plural and shall have the gender
as required by the text.

 

13.
Headings. The various headings used in this Note as headings for sections or otherwise are for convenience and reference
only and shall not be used in interpreting the text of the section in which they appear and shall not limit or otherwise affect
the meanings thereof.

 

14.
Time of Essence. Time is of the essence with this Note.

 

15.
Severability. If any part of this Note is construed to be in violation of any law, such part shall be modified to achieve
the objective of the Parties to the fullest extent permitted by law and the balance of this Note shall remain in full force and
effect.

 

16.
Attorneys’ Fees. If any action at law or in equity is necessary to enforce this Note or to collect payment under
this Note, the Lender shall be entitled to recover reasonable attorneys’ fees directly related to such enforcement or collection
actions.

 

17.
Amendments and Waivers; Remedies. No failure or delay on the part of either Party hereto in exercising any right, power
or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy
preclude any other or further exercise thereof or the exercise of any other right, power or remedy. The remedies provided for
herein are cumulative and are not exclusive of any remedies that may be available to either Party hereto at law, in equity or
otherwise. Any amendment, supplement or modification of or to any provision of this Note, any waiver of any provision of this
Note, and any consent to any departure by either Party from the terms of any provision of this Note, shall be effective (i) only
if it is made or given in writing and signed by the Borrower and the Lender and (ii) only in the specific instance and for the
specific purpose for which made or given.

 

18.
Notices. Unless otherwise provided for herein, all notices, requests, demands, claims and other communications hereunder
shall be given in accordance with the subsection of the Purchase Agreement titled “Notices.”
Either Party may change the address to which notices, requests, demands, claims and other communications hereunder are
to be delivered by providing notice thereof in the manner set forth in the Purchase Agreement.

 

19.
Final Note. This Note, together with the other Transaction Documents, contains the complete understanding and agreement
of the Borrower and the Lender and supersedes all prior representations, warranties, agreements, arrangements, understandings,
and negotiations of the Borrower and Lender with respect to the subject matter of the Transaction Documents. THIS NOTE, TOGETHER
WITH THE OTHER TRANSACTION DOCUMENTS, REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE
OF ANY ALLEGED PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN
THE PARTIES.

 

[Remainder
of page intentionally left blank]

 

    	4

    	 

    

 

IN
WITNESS WHEREOF, the Parties have executed this Note as of the date set forth above.

 

	 	BORROWER:
	 	 
	 	Iliad
    Research and Trading, L.P.
	 	 	 	 	 
	 	By:	Iliad
    Management, LLC, its General Partner
	 	 	 	 	 
	 	 	By:	Fife
    Trading, Inc., its Manager
	 	 	 	 	 
	 	 	 	By:	 
	 	 	 	 	John
    M. Fife, President

 

ACKNOWLEDGED,
ACCEPTED AND AGREED:

 

Seaniemac
International, Ltd.

 

	By:	 	 
	Name:	 	 
	Title:	 	 

 

    	5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]